In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...
Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...
What's a Cancer like? Just ask the friends and family in their lives — you won't find a more devoted person. As a fourth sign of the zodiac and the first water sign in the celestial lineup, Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback